MedPath

Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis

Completed
Conditions
Acute Gastroenteritis
Dehydration
Registration Number
NCT04555200
Lead Sponsor
University Hospital, Brest
Brief Summary

When oral rehydration is impossible, enteral rehydration via the nasogastric route has been the recommended method of rehydration since 2008 by ESPGHAN ( European Society for Paediatric Gastroenterology Hepatology and Nutrition ), for children with acute gastroenteritis. However, these recommendations are rarely followed in France. These recommendations were not applied in the Children's Emergency Department of BREST University Hospital. The investigators changed the protocol and shared it with the caregivers of the emergency unit. The investigators studied the impact of this change of protocol

Detailed Description

The main purpose was to assess the proportion of children rehydrated by nasogastric tube(NG) after protocol change. Secondary outcomes were to assess hospital length of stay and sides effects.

It is a retro and prospective study. The first phase took place from June to September 2018 and the second from June to September 2019. Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria

Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included

Exclusion Criteria
  • acute gastroenteritis on return from tropical countries
  • child with endocrine system diseases requiring parenteral rehydration
  • history of chronic pathology requiring enteral feeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of nasogastric tube after changing gastroenteritis rehydration protocol4 months

assessed by the number of NG tube and IV in each group

Secondary Outcome Measures
NameTimeMethod
Hospital lenght of stay between each group4 months

evaluate by administrative data of each case (arrival time and departure time)

Number of Participants With Treatment-Related Adverse Events for each method4 months

Serious sides effect were death and epilptic seizure. Mild sides effects were multiple (IV or NG ripped out, vomiting, failure...).

Trial Locations

Locations (1)

CHRU de Brest (urgences pédiatriques)

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath